CD8A and neoplasm: FOLR1-specific CAR candidates designed with IgG4 hinge (candidates C and G) are associated with slower tumor-killing kinetics, reduced proliferation capacities, and persistency compared to the CAR candidates designed with CD8α hinge (candidates A and E) (Figure 3b–e).